Fmr LLC Kezar Life Sciences, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Fmr LLC holds 62,288 shares of KZR stock, worth $459,062. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,288

Previous 22,089 181.99%

Holding current value

$459,062

Previous $19,000 94.74%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.6 - $0.92 $24,119 - $36,983	40,199 Added 181.99%	62,288 $37,000
Q1 2024 May 13, 2024	BUY	$0.8 - $1.05 $2,860 - $3,753	3,575 Added 19.31%	22,089 $19,000
Q4 2023 Feb 13, 2024	BUY	$0.72 - $1.15 $8,067 - $12,885	11,205 Added 153.3%	18,514 $17,000
Q3 2023 Nov 13, 2023	SELL	$1.08 - $2.54 $34,414 - $80,937	-31,865 Reduced 81.34%	7,309 $8,000
Q2 2023 Aug 11, 2023	SELL	$2.31 - $3.06 $3,762 - $4,984	-1,629 Reduced 3.99%	39,174 $95,000
Q1 2023 May 11, 2023	SELL	$3.13 - $7.31 $140,001 - $326,968	-44,729 Reduced 52.3%	40,803 $127,000
Q4 2022 Feb 13, 2023	SELL	$6.39 - $8.8 $179,009 - $246,523	-28,014 Reduced 24.67%	85,532 $602,000
Q3 2022 Nov 10, 2022	BUY	$7.99 - $10.75 $2,061 - $2,773	258 Added 0.23%	113,546 $978,000
Q2 2022 Aug 12, 2022	BUY	$4.58 - $17.13 $334,596 - $1.25 Million	73,056 Added 181.59%	113,288 $937,000
Q1 2022 May 13, 2022	BUY	$12.3 - $18.33 $494,853 - $737,452	40,232 New	40,232 $669,000

Others Institutions Holding KZR

# of Institutions

Shares Held

39.8M

Call Options Held

3.2K

Put Options Held

700

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $504M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account